ng-nitroarginine methyl ester has been researched along with Left Ventricular Hypertrophy in 48 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 16 (33.33) | 18.2507 |
2000's | 24 (50.00) | 29.6817 |
2010's | 7 (14.58) | 24.3611 |
2020's | 1 (2.08) | 2.80 |
Authors | Studies |
---|---|
Hasmono, D; Hijriani, N; Yusetyani, L | 1 |
Coelho-Filho, OR; Das, S; Jerosch-Herold, M; Kwong, R; Mitchell, R; Moreno, H; Neilan, TG; Rosenzweig, A; Shah, RV; Simonson, B | 1 |
Bunbupha, S; Kukongviriyapan, U; Kukongviriyapan, V; Pakdeechote, P; Prachaney, P; Welbat, JU | 1 |
Fujita, M; Iwasaka, T; Otani, H; Shimazu, T; Shiojima, I; Yoshioka, K | 1 |
Bhimaraj, A; Celis, R; Cordero-Reyes, AM; Estep, JD; Flores-Arredondo, JH; Hamilton, DJ; Orrego, CM; Torre-Amione, G; Trevino, AR; Youker, KA | 1 |
Behuliak, M; Celec, P; Hojna, S; Kojsova, S; Kunes, J; Paulis, L; Pechanova, O; Simko, F; Zicha, J | 1 |
Rossi, MA | 1 |
Bonney, W; Cheema, FH; Gonzalez, AM; Homma, S; Kinnear, C; Liao, JK; Mahmut, N; Martens, TP; Mital, S; Osorio, JC | 1 |
Cho, HS; Kim, WK; Lee, J; Park, S | 1 |
Chen, WM; Deng, J; Huang, XN; Wang, YW; Wu, Q | 1 |
Babál, P; Hlavačková, L; Janega, P; Pecháňová, O; Vranková, S | 1 |
Burns, KD; deBlois, D; Hale, TM; Robertson, SJ | 1 |
Itoh, M; Kubota, I; Miyamoto, T; Shishido, T; Takahashi, H; Takeishi, Y; Tomoike, H | 1 |
Prado, CM; Ramos, SG; Rossi, MA | 1 |
Charo, IF; Egashira, K; Hiasa, K; Inoue, S; Ishibashi, M; Ishibashi, T; Kitamoto, S; Kura, S; Ohtani, K; Sugaya, T; Takeshita, A; Tsuchihashi, M; Tsuzuki, T; Zhao, Q | 1 |
Gröne, HJ; Gross, V; Janke, J; Kiss, E; Langenickel, TH; Luft, FC; Mazak, I; Müller, DN; Obst, M; Shagdarsuren, E | 1 |
Andriantsitohaina, R; Babál, P; Bernátová, I; Kyselá, S; Martínez, MC; Pechánová, O; Stvrtina, S | 1 |
Deuchar, GA; Hicks, MN; MacLean, MR | 1 |
Abe, Y; Date, T; Mochizuki, S; Nagai, M; Okada, T; Seki, S; Tanaka, Y; Taniguchi, I; Taniguchi, M | 1 |
Babal, P; Bernatova, I; Gvozdjakova, A; Krajcirovicova, K; Kucharska, J; Luptak, I; Matuskova, J; Pechanova, O; Simko, F; Simko, J; Sumbalova, Z | 1 |
Jendeková, L; Kojsová, S; Pechánová, O; Sládková, M | 1 |
Adamcová, M; Krajcírovicová, K; Matúsková, J; Paulis, L; Pechánová, O; Pelouch, V; Potácová, A; Simko, F | 1 |
Krajcírovicová, K; Lupták, I; Matúsková, J; Paulis, L; Pechánová, O; Pelouch, V; Pincíková, T; Pomsár, J; Simko, F; Stvrtina, S | 1 |
Barbosa Neto, O; Blanco, JH; Martin-Pinge, MC; Penteado, DM; Silva, VJ; Souza, HC; Teixeira, Vde P | 1 |
Braun-Dullaeus, RC; Ebner, B; Heerwagen, C; Kasper, M; Morawietz, H; Schmeisser, A; Schober, K; Schwencke, C; Strasser, RH; Wunderlich, C | 1 |
Adamcova, M; Hulin, I; Janega, P; Krajcirovicova, K; Matuskova, J; Paulis, L; Pechanova, O; Pelouch, V; Potacova, A; Simko, F; Simko, J | 1 |
Appay, MD; Arnal, JF; Bariety, J; Hinglais, N; Laboulandine, I; Michel, JB; Xu, Y | 1 |
Fujita, H; Itoh, H; Nakagawa, M; Nakamura, K; Nakata, T; Sasaki, S; Takeda, K; Tanaka, M; Uchida, A | 1 |
Arnal, JF; Chatellier, G; el Amrani, AI; Ménard, J; Michel, JB | 1 |
Sadoff, JD; Scholz, PM; Tse, J; Weiss, HR | 1 |
Endo, T; Hayakawa, H; Kaneko, H; Kiuchi, K | 1 |
Bernátová, I; Pechánová, O | 1 |
Bernátová, I; Pechánová, O; Simko, F | 1 |
Devát, L; Gerová, M; Kristek, F; Varga, I | 1 |
Devát, L; Gerová, M; Sládek, T; Znojil, V | 1 |
Dolezel, S; Gerová, M; Hartmannová, B; Jezek, L | 1 |
Laverty, R; Ledingham, JM | 1 |
Anderson, NH; Brosnan, MJ; Clark, JS; Devlin, AM; Dominiczak, AF; Graham, D; Hamilton, CA; McPhaden, A; Reid, JL | 1 |
Akuzawa, N; Hoshino, J; Kurashina, T; Nagai, R; Nakamura, T; Ono, Z; Saito, Y; Sakamoto, H; Sumino, H | 1 |
Franco, M; Janicki, JS; Matsubara, BB; Matsubara, LS; Zornoff, LA | 1 |
Aizawa, H; Akuzawa, N; Kurashina, T; Nagai, R; Nakamura, T; Ono, Z; Saito, Y; Sakamoto, H; Sumino, H | 1 |
Babál, P; Bernátová, I; Pechánová, O | 1 |
Antunes, E; Cintra, KA; De Luca, IM; De Nucci, G; de Oliveira, CF; Teixeira, SA | 1 |
Bernátová, I; Pechánová, O; Pelouch, V; Simko, F | 1 |
Laverty, R; Ledingham, JM; Orange, SJ | 1 |
Mandarim-De-Lacerda, CA; Pereira, LM | 1 |
Brown, NJ; Fogo, AB; Kaikita, K; Ma, L; Schoenhard, JA; Vaughan, DE | 1 |
Antunes, E; de Azevedo, AP; De Luca, IM; De Nucci, G; De Oliveira, CF; Pacca, SR | 1 |
1 review(s) available for ng-nitroarginine methyl ester and Left Ventricular Hypertrophy
Article | Year |
---|---|
Left ventricular hypertrophy and arterial blood pressure in experimental models of hypertension.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Disease Susceptibility; Humans; Hypertension; Hypertrophy; Hypertrophy, Left Ventricular; NG-Nitroarginine Methyl Ester; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Rats, Inbred WKY | 1997 |
47 other study(ies) available for ng-nitroarginine methyl ester and Left Ventricular Hypertrophy
Article | Year |
---|---|
The effect of curcuma (Curcuma xanthorrizha roxb.) extract as an adjuvant of captopril therapy on cardiac histopathology of male mice (Mus musculus) with hypertension.
Topics: Adjuvants, Pharmaceutic; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Captopril; Curcuma; Enzyme Inhibitors; Hypertension; Hypertrophy, Left Ventricular; Male; Mice; NG-Nitroarginine Methyl Ester; Plant Extracts; Treatment Outcome | 2020 |
Quantification of cardiomyocyte hypertrophy by cardiac magnetic resonance: implications for early cardiac remodeling.
Topics: Algorithms; Animals; Aortic Valve Stenosis; Biomarkers; Body Water; Cardiomyopathy, Hypertrophic; Cell Size; Contrast Media; Gadolinium DTPA; Hypertension; Hypertrophy; Hypertrophy, Left Ventricular; Magnetic Resonance Imaging; Male; Mice; Myocytes, Cardiac; NG-Nitroarginine Methyl Ester; Phenotype; Random Allocation; Ventricular Remodeling | 2013 |
Asiatic acid alleviates cardiovascular remodelling in rats with L-NAME-induced hypertension.
Topics: Animals; Antihypertensive Agents; Aorta; Biomarkers; Blood Pressure; Collagen; Disease Models, Animal; Fibrosis; Hypertension; Hypertrophy, Left Ventricular; Male; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitrites; Pentacyclic Triterpenes; Rats, Sprague-Dawley; Time Factors; Tumor Necrosis Factor-alpha; Vascular Remodeling; Ventricular Remodeling | 2015 |
Sepiapterin prevents left ventricular hypertrophy and dilatory remodeling induced by pressure overload in rats.
Topics: Animals; Aorta; Biopterins; Capillaries; Cell Size; Constriction; Dilatation, Pathologic; Enzyme Inhibitors; Glycine; Heart; Hypertrophy, Left Ventricular; Male; Myocardium; Myocytes, Cardiac; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Organ Size; Oxidative Stress; Pressure; Pterins; Rats; Rats, Sprague-Dawley; Sulfhydryl Compounds; Ultrasonography; Ventricular Dysfunction, Left; Ventricular Remodeling | 2015 |
Full Expression of Cardiomyopathy Is Partly Dependent on B-Cells: A Pathway That Involves Cytokine Activation, Immunoglobulin Deposition, and Activation of Apoptosis.
Topics: Angiotensin II; Animals; Apoptosis; B-Lymphocytes; Cardiomyopathies; Collagen; Cytokines; Disease Models, Animal; Fibroblasts; Fibrosis; Genetic Predisposition to Disease; Heart Failure; Hypertrophy, Left Ventricular; Immunoglobulin G; Magnetic Resonance Imaging; Male; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, SCID; Myocardium; NG-Nitroarginine Methyl Ester; Phenotype; Sialic Acid Binding Ig-like Lectin 2; Signal Transduction; Sodium Chloride; Stroke Volume; Time Factors; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2016 |
Regression of L-NAME-induced hypertension: the role of nitric oxide and endothelium-derived constricting factor.
Topics: Animals; Aorta; Blood Pressure; Disease Models, Animal; Endothelins; Enzyme Inhibitors; Femoral Artery; Hypertension; Hypertrophy, Left Ventricular; Male; Mesenteric Arteries; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Organ Size; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; RNA, Messenger; Signal Transduction | 2008 |
The muscle-collagen ratio in left ventricular hypertrophy and aorta remodelling in hypertension.
Topics: Animals; Aorta; Collagen; Hypertension; Hypertrophy, Left Ventricular; Models, Animal; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats | 2008 |
Simvastatin reverses cardiac hypertrophy caused by disruption of the bradykinin 2 receptor.
Topics: Animals; Blood Pressure; Cardiomegaly; Enzyme Inhibitors; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertrophy, Left Ventricular; Mice; Mice, Knockout; Mitogen-Activated Protein Kinases; Myocytes, Cardiac; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Phosphorylation; Platelet Endothelial Cell Adhesion Molecule-1; Receptor, Bradykinin B1; Receptor, Bradykinin B2; Signal Transduction; Simvastatin; Stroke Volume; Ultrasonography | 2008 |
Regular exercise produced cardioprotective effects on rat's heart with hypertension induced by L-NAME administration.
Topics: Angiotensin II; Animals; Apoptosis; Blood Pressure; Body Weight; Disease Models, Animal; Heart; Hypertension; Hypertrophy, Left Ventricular; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Physical Conditioning, Animal; Rats | 2009 |
Role of nitric oxide in ginsenoside Rg(1)-induced protection against left ventricular hypertrophy produced by abdominal aorta coarctation in rats.
Topics: Abdomen; Animals; Aortic Coarctation; Arginine; Atrial Natriuretic Factor; Cardiovascular Agents; Disease Models, Animal; Endothelium; Ginsenosides; Heart Ventricles; Hypertrophy, Left Ventricular; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Organ Size; Panax; Phytotherapy; Random Allocation; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2010 |
The effect of indapamide on development of myocardial hypertrophy and fibrosis in L-NAME-induced hypertension in rat.
Topics: Animals; Captopril; Collagen Type I; Collagen Type III; Fibrosis; Hypertension; Hypertrophy, Left Ventricular; Indapamide; Male; Myocardium; NG-Nitroarginine Methyl Ester; Rats; Rats, Wistar | 2011 |
Short-term ACE inhibition confers long-term protection against target organ damage.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cell Proliferation; Creatinine; Disease Models, Animal; Enalapril; Fibrosis; Hypertension; Hypertrophy, Left Ventricular; Kidney; Male; NG-Nitroarginine Methyl Ester; Rats; Rats, Inbred SHR; Urea | 2012 |
Role of nitric oxide in the progression of cardiovascular remodeling induced by carotid arterio-venous shunt in rabbits.
Topics: Animals; Cardiac Output; Disease Progression; Enzyme Inhibitors; Hemodynamics; Hypertrophy, Left Ventricular; Hypertrophy, Right Ventricular; Male; Models, Animal; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rabbits; Random Allocation; Ventricular Function, Left; Ventricular Remodeling | 2003 |
Chronic inhibition of nitric oxide synthase induces hypertension and cardiomyocyte mitochondrial and myocardial collagen remodelling in the absence of hypertrophy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Captopril; Collagen; Disease Models, Animal; Enzyme Inhibitors; Heart Ventricles; Hypertension; Hypertrophy, Left Ventricular; Male; Mitochondria, Heart; Models, Cardiovascular; Myocardium; Myocytes, Cardiac; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Predictive Value of Tests; Randomized Controlled Trials as Topic; Rats; Rats, Wistar; Severity of Illness Index; Time Factors; Treatment Outcome | 2003 |
Critical role of monocyte chemoattractant protein-1 receptor CCR2 on monocytes in hypertension-induced vascular inflammation and remodeling.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Bone Marrow Transplantation; Chemokine CCL2; Chemotaxis, Leukocyte; Enzyme Inhibitors; Humans; Hypertension; Hypertrophy, Left Ventricular; Imidazoles; Inflammation; Infusion Pumps, Implantable; Male; Mice; Mice, Inbred C57BL; Monocytes; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Olmesartan Medoxomil; Pilot Projects; Radiation Chimera; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptors, CCR2; Receptors, Chemokine; Recombinant Fusion Proteins; Superoxide Dismutase; Tetrazoles; Up-Regulation | 2004 |
Cardiac hypertrophy and fibrosis in chronic L-NAME-treated AT2 receptor-deficient mice.
Topics: Animals; Blood Pressure; Enzyme Inhibitors; Fibrosis; Heart Rate; Hypertension; Hypertrophy, Left Ventricular; Male; Mice; Mice, Mutant Strains; NG-Nitroarginine Methyl Ester; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Ventricular Function, Left | 2004 |
Red wine polyphenols prevent cardiovascular alterations in L-NAME-induced hypertension.
Topics: Alkadienes; Animals; Aortic Diseases; Blood Pressure; Blotting, Western; Carbon Radioisotopes; Enzyme Inhibitors; Flavonoids; Hypertension; Hypertrophy, Left Ventricular; Leucine; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Norepinephrine; Phenols; Polyphenols; Rats; Rats, Wistar; Vasoconstrictor Agents; Wine | 2004 |
The role of 5-hydroxytryptamine in the control of pulmonary vascular tone in a rabbit model of pulmonary hypertension secondary to left ventricular dysfunction.
Topics: Animals; Aorta; Blood Pressure; Cardiac Output; Disease Models, Animal; Heart Rate; Hypertension, Pulmonary; Hypertrophy, Left Ventricular; Hypertrophy, Right Ventricular; Ketanserin; Male; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Organ Size; Pulmonary Artery; Rabbits; Receptor, Serotonin, 5-HT2A; Serotonin; Serotonin Antagonists; Stroke Volume; Ventricular Dysfunction, Left | 2005 |
Effects of bradykinin on cardiovascular remodeling in renovascular hypertensive rats.
Topics: Adrenergic beta-Antagonists; Animals; Atrial Natriuretic Factor; Blood Pressure; Body Weight; Bradykinin; Coronary Circulation; Echocardiography; Enzyme Inhibitors; Fibrosis; Hypertension, Renal; Hypertrophy, Left Ventricular; Male; Myocardium; Natriuretic Peptide, Brain; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Organ Size; Rats; Rats, Wistar; RNA, Messenger; Ventricular Remodeling | 2004 |
L-arginine fails to protect against myocardial remodelling in L-NAME-induced hypertension.
Topics: Animals; Antihypertensive Agents; Arginine; Brain; Hydroxyproline; Hypertension; Hypertrophy, Left Ventricular; Kidney; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Wistar; Ubiquinone | 2005 |
Chronic and acute effects of different antihypertensive drugs on femoral artery relaxation of L-NAME hypertensive rats.
Topics: Acetylcholine; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Captopril; Disease Models, Animal; Diuretics; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Femoral Artery; Heart Ventricles; Hydrochlorothiazide; Hypertension; Hypertrophy, Left Ventricular; Indapamide; NG-Nitroarginine Methyl Ester; Nitric Oxide; Organ Size; Rats; Rats, Wistar; Vasodilation; Vasodilator Agents | 2007 |
Spontaneous, L-arginine-induced and spironolactone-induced regression of protein remodeling of the left ventricle in L-NAME-induced hypertension.
Topics: Animals; Arginine; Blood Pressure; Collagen; Hypertension; Hypertrophy, Left Ventricular; Male; Mineralocorticoid Receptor Antagonists; Muscle Proteins; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Organ Size; Rats; Rats, Wistar; Remission, Spontaneous; Spironolactone; Ventricular Remodeling | 2007 |
Spironolactone differently influences remodeling of the left ventricle and aorta in L-NAME-induced hypertension.
Topics: Animals; Antihypertensive Agents; Aorta; Blood Pressure; Cell Proliferation; DNA Replication; Heart Ventricles; Hypertension; Hypertrophy, Left Ventricular; Kidney; Male; Mineralocorticoid Receptor Antagonists; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Wistar; Spironolactone; Time Factors; Ventricular Remodeling | 2007 |
Nitric oxide synthesis blockade increases hypertrophy and cardiac fibrosis in rats submitted to aerobic training.
Topics: Adaptation, Physiological; Analysis of Variance; Animals; Blood Pressure; Disease Models, Animal; Endomyocardial Fibrosis; Enzyme Inhibitors; Heart Rate; Hypertension; Hypertrophy, Left Ventricular; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Physical Conditioning, Animal; Rats; Rats, Wistar; Swimming | 2007 |
Chronic NOS inhibition prevents adverse lung remodeling and pulmonary arterial hypertension in caveolin-1 knockout mice.
Topics: Animals; Blood Pressure; Caveolin 1; Enzyme Inhibitors; Hypertension, Pulmonary; Hypertrophy, Left Ventricular; Liver; Lung; Mice; Mice, Knockout; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Organ Size; Oxidants; Oxidative Stress; Phenotype; Physical Conditioning, Animal; Pulmonary Artery; Respiratory Function Tests; Signal Transduction; Superoxides | 2008 |
Regression of left ventricular hypertrophy and aortic remodelling in NO-deficient hypertensive rats: effect of L-arginine and spironolactone.
Topics: Animals; Aorta; Arginine; Fibrosis; Hypertension; Hypertrophy, Left Ventricular; Male; Mineralocorticoid Receptor Antagonists; Models, Animal; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Wistar; Spironolactone | 2008 |
Renal hypertensive angiopathy. Comparison between chronic NO suppression and DOCA-salt intoxication.
Topics: Animals; Aorta; Arginine; Blood Pressure; Blood Urea Nitrogen; Body Weight; Creatinine; Cyclic GMP; Desoxycorticosterone; Disease Models, Animal; Hypertension, Renal; Hypertrophy, Left Ventricular; Male; Mortality; NG-Nitroarginine Methyl Ester; Proteinuria; Rats; Rats, Wistar; Renin-Angiotensin System | 1995 |
Effect of an angiotensin II receptor antagonist, TCV-116, on cardiac hypertrophy and coronary circulation in spontaneously hypertensive rats.
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Arginine; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cardiomegaly; Coronary Circulation; Coronary Vessels; Heart Rate; Hypertension; Hypertrophy, Left Ventricular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Prodrugs; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrazoles; Vascular Resistance | 1994 |
Cardiac weight in hypertension induced by nitric oxide synthase blockade.
Topics: Angiotensins; Animals; Arginine; Atrial Natriuretic Factor; Dose-Response Relationship, Drug; Heart Ventricles; Hypertension; Hypertrophy, Left Ventricular; Myocardium; NG-Nitroarginine Methyl Ester; Organ Size; Rats; Rats, Wistar; Renin; Time Factors | 1993 |
Increased guanylate cyclase activity is associated with an increase in cyclic guanosine 3',5'-monophosphate in left ventricular hypertrophy.
Topics: Animals; Arginine; Cyclic GMP; Dogs; Female; Guanylate Cyclase; Hypertrophy, Left Ventricular; Male; Molsidomine; NG-Nitroarginine Methyl Ester; Oxygen Consumption | 1996 |
Inhibition of nitric oxide synthesis reduces coronary blood flow response but does not increase cardiac contractile response to beta-adrenergic stimulation in normal dogs.
Topics: Acetylcholine; Adrenergic beta-Agonists; Animals; Coronary Circulation; Dogs; Female; Heart Rate; Hemodynamics; Hypertrophy, Left Ventricular; Isoproterenol; Male; Myocardial Contraction; NG-Nitroarginine Methyl Ester; Nitric Oxide | 1996 |
Effect of long-term NO synthase inhibition on cyclic nucleotide content in rat tissues.
Topics: Animals; Aorta; Blood Pressure; Brain; Cyclic AMP; Cyclic GMP; Enzyme Inhibitors; Hypertrophy, Left Ventricular; Kidney; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Wistar; Time Factors | 1996 |
Captopril prevents NO-deficient hypertension and left ventricular hypertrophy without affecting nitric oxide synthase activity in rats.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Disease Models, Animal; Enzyme Inhibitors; Evaluation Studies as Topic; Hypertension; Hypertrophy, Left Ventricular; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Wistar; Time Factors | 1996 |
Remodelling of septal branch of coronary artery and carotid artery in L-NAME treated rats.
Topics: Animals; Blood Pressure; Carotid Arteries; Coronary Vessels; Enzyme Inhibitors; Hypertrophy, Left Ventricular; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar; Tunica Intima; Tunica Media | 1996 |
Morphometric characteristics of cardiac hypertrophy induced by long-term inhibition of NO synthase.
Topics: Animals; Blood Pressure; Capillaries; Coronary Circulation; Enzyme Inhibitors; Hypertrophy, Left Ventricular; Male; Microcirculation; Muscle Fibers, Skeletal; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Wistar; Time Factors | 1996 |
Long-term inhibition of NO synthase induces cardiac hypertrophy with a decrease in adrenergic innervation.
Topics: Adrenergic Fibers; Animals; Blood Pressure; Enzyme Inhibitors; Heart; Heart Rate; Hypertension; Hypertrophy, Left Ventricular; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Organ Size; Rats; Rats, Wistar; Time Factors | 1996 |
Nitric oxide synthase inhibition with N omega-nitro-L-arginine methyl ester affects blood pressure and cardiovascular structure in the genetically hypertensive rat strain.
Topics: Animals; Blood Pressure; Endothelium, Vascular; Hypertension; Hypertrophy, Left Ventricular; Mesenteric Arteries; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Mutant Strains; Rats, Wistar; Vascular Resistance | 1997 |
Antihypertensive agents prevent nephrosclerosis and left ventricular hypertrophy induced in rats by prolonged inhibition of nitric oxide synthesis.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Enzyme Inhibitors; Hypertrophy, Left Ventricular; Imidazoles; Imidazolidines; Male; Nephrosclerosis; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar | 1998 |
Left ventricular adaptation to chronic pressure overload induced by inhibition of nitric oxide synthase in rats.
Topics: Adaptation, Physiological; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Follow-Up Studies; Heart Ventricles; Hypertension; Hypertrophy, Left Ventricular; Lisinopril; Male; Myocardial Contraction; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Organ Size; Random Allocation; Rats; Rats, Wistar; Ventricular Pressure | 1998 |
ET(A) receptor antagonist ameliorates nephrosclerosis and left ventricular hypertrophy induced in rat by prolonged inhibition of nitric oxide synthesis.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Drug Combinations; Endothelin Receptor Antagonists; Enzyme Inhibitors; Hypertension; Hypertrophy, Left Ventricular; Imidazoles; Imidazolidines; Male; Nephrosclerosis; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar; Receptor, Endothelin A; Time Factors | 1998 |
Structural alterations in the heart after long-term L-NAME and D-NAME treatment.
Topics: Animals; Blood Pressure; Enzyme Inhibitors; Fibrosis; Heart; Hypertrophy, Left Ventricular; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Wistar; Stereoisomerism | 1999 |
Development of cardiomyocyte hypotrophy in rats under prolonged treatment with a low dose of a nitric oxide synthesis inhibitor.
Topics: Animals; Blood Pressure; Body Weight; Brain; Cardiomegaly; Enzyme Inhibitors; Fibrosis; Hypertrophy, Left Ventricular; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type III; Organ Size; Rats; Rats, Wistar | 2000 |
Regression of chronic L -NAME-treatment-induced left ventricular hypertrophy: effect of captopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Captopril; Collagen; DNA; Heart Ventricles; Hypertension; Hypertrophy, Left Ventricular; Male; Muscle Proteins; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Organ Size; Rats; Rats, Wistar; Remission, Spontaneous; Renin-Angiotensin System; RNA; Ventricular Remodeling | 2000 |
Cardiovascular effects of chronic nitric oxide synthase inhibition in genetically hypertensive rats.
Topics: Aging; Animals; Blood Pressure; Cardiomegaly; Dose-Response Relationship, Drug; Enzyme Inhibitors; Heart Rate; Hemodynamics; Hindlimb; Hypertension; Hypertrophy, Left Ventricular; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Wistar; Regional Blood Flow | 2000 |
The effect of enalapril and verapamil on the left ventricular hypertrophy and the left ventricular cardiomyocyte numerical density in rats submitted to nitric oxide inhibition.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cell Count; Enalapril; Enzyme Inhibitors; Hypertrophy, Left Ventricular; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Plethysmography; Rats; Rats, Wistar; Statistics, Nonparametric; Verapamil | 2001 |
Plasminogen activator inhibitor-1 deficiency prevents hypertension and vascular fibrosis in response to long-term nitric oxide synthase inhibition.
Topics: Animals; Blood Pressure; Body Weight; Collagen; Coronary Vessels; Enzyme Inhibitors; Fibrosis; Hemodynamics; Hypertension; Hypertrophy, Left Ventricular; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Plasminogen Activator Inhibitor 1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time | 2001 |
Attenuation of hypertension, cardiomyocyte hypertrophy, and myocardial fibrosis by beta-adrenoceptor blockers in rats under long-term blockade of nitric oxide synthesis.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Atenolol; Blood Pressure; Body Weight; Enzyme Inhibitors; Fibrosis; Heart; Hypertension; Hypertrophy, Left Ventricular; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Organ Size; Propranolol; Rats; Rats, Wistar; Time Factors | 2002 |